131 related articles for article (PubMed ID: 21514632)
1. Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer.
Mabuchi S; Matsumoto Y; Isohashi F; Yoshioka Y; Ohashi H; Morii E; Hamasaki T; Aozasa K; Mutch DG; Kimura T
Gynecol Oncol; 2011 Jul; 122(1):25-32. PubMed ID: 21514632
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
Lee YY; Choi CH; Kim HJ; Kim TJ; Lee JW; Lee JH; Bae DS; Kim BG
Anticancer Res; 2012 Apr; 32(4):1555-61. PubMed ID: 22493401
[TBL] [Abstract][Full Text] [Related]
4. The first 2 cases of granulocyte colony-stimulating factor producing adenocarcinoma of the uterine cervix.
Mabuchi S; Matsumoto Y; Morii E; Morishige K; Kimura T
Int J Gynecol Pathol; 2010 Sep; 29(5):483-7. PubMed ID: 20736776
[TBL] [Abstract][Full Text] [Related]
5. [The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in gynecological cancer patients].
Czygier M; Ławicki S; Gacuta-Szumarska E; Bedkowska E; Szmitkowski M
Przegl Lek; 2010; 67(3):184-6. PubMed ID: 20687382
[TBL] [Abstract][Full Text] [Related]
6. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
7. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6.
Kyo S; Kanaya T; Takakura M; Inoue M
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):383-7. PubMed ID: 10985899
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
9. Nomogram prediction of overall survival after curative irradiation for uterine cervical cancer.
Seo Y; Yoo SY; Kim MS; Yang KM; Yoo HJ; Kim JH; Shin YJ; Kang JK; Lee KH; Lee ED; Rhu SY; Choi SC; Kim MH; Kim BJ; Kim MS; Cho CK
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):782-7. PubMed ID: 20472352
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor.
Nasu K; Inoue C; Takai N; Kashima K; Miyakawa I
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1086-8. PubMed ID: 15516405
[TBL] [Abstract][Full Text] [Related]
11. Systemic leukocyte alterations are associated with invasive uterine cervical cancer.
Tavares-Murta BM; Mendonça MA; Duarte NL; da Silva JA; Mutão TS; Garcia CB; Murta EF
Int J Gynecol Cancer; 2010 Oct; 20(7):1154-9. PubMed ID: 21495217
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor: a report of 4 cases and a review of the literature.
Matsumoto Y; Mabuchi S; Muraji M; Morii E; Kimura T
Int J Gynecol Cancer; 2010 Apr; 20(3):417-21. PubMed ID: 20375807
[TBL] [Abstract][Full Text] [Related]
13. Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer.
Cho H; Kim JH
Biomarkers; 2009 May; 14(3):161-70. PubMed ID: 19399661
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
15. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
Lee YY; Choi CH; Kim CJ; Song TJ; Kim MK; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2010 Mar; 116(3):459-63. PubMed ID: 20004008
[TBL] [Abstract][Full Text] [Related]
16. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
Atasii T; Aksu MF; Cetinkaya MB
Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
[TBL] [Abstract][Full Text] [Related]
19. Leukocytosis as an initial sign of aggressive growth of granulocyte colony-stimulating factor-producing cervical cancer.
Yabuta M; Takeuchi K; Kitazawa S; Morita H
Int J Gynaecol Obstet; 2010 Nov; 111(2):181-2. PubMed ID: 20708178
[No Abstract] [Full Text] [Related]
20. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature.
Mabuchi S; Matsumoto Y; Kawano M; Minami K; Seo Y; Sasano T; Takahashi R; Kuroda H; Hisamatsu T; Kakigano A; Hayashi M; Sawada K; Hamasaki T; Morii E; Kurachi H; Matsuura N; Kimura T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24948742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
